Myeloma

Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer

FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

Kite, a Gilead Company Named Presenting Sponsor of Celebration & Community for LLS’s National Light The Night Events

22 Nonprofits Representing Patients Applaud ‘Family Glitch’ Fix as a Monumental Move to Expand Coverage

BURLINGTON STORES AND THE LEUKEMIA & LYMPHOMA SOCIETY CONTINUE THEIR PARTNERSHIP IN THE FIGHT AGAINST BLOOD CANCER

The Leukemia & Lymphoma Society Financial Relief Fund Commits Over $1 Million in Direct Support to Blood Cancer Patients Impacted by Hurricanes Fiona & Ian

Research Infrastructure to Promote Enrollment of Underserved Patients on Clinical Trials

Submitted by giriczo on October 1, 2022

Uncovering the role of TCL1A as a driver of clonal hematopoiesis and hematological malignancies

Submitted by giriczo on October 1, 2022
Subscribe to Myeloma

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.